| Purpose | Board Meetings Date | Announcement Date |
|---|---|---|
| Board Meeting | 17 Oct 2025 | 17 Oct 2025 |
| In compliance with Regulation 30 of Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, this is to inform Stock Exchange that the Board of Directors of the Company at their meeting held on Friday, 17th October 2025 at 11.00 A.M. has, inter alia, considered and approved the following: 1. Took note of Resignation of Independent Director - Dhaval Jayant Soni. The brief information as required under Regulation 30 of SEBI (LODR) regulations, 2015 for the said matter is enclosed as Annexure A. 2. Change of place for keeping the Books of Accounts & Corporate Office Address. The brief information as required under Regulation 30 of SEBI (LODR) regulations, 2015 for the said matter is enclosed as Annexure B. The Meeting of the Board of Directors of the Company was commenced at 11.00 A.M. and concluded at 11.40 A.M. | ||
| Board Meeting | 22 Aug 2025 | 22 Aug 2025 |
| In compliance with Regulation 30 of Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, this is to inform Stock Exchange that the Board of Directors of the Company at their meeting held on Friday, 22nd August 2025 at 11.30 A.M. has, inter alia, considered and approved the agenda items as listed in the attached outcome. The Meeting of the Board of Directors of the Company was commenced at 11.30 A.M. and concluded at 02.00 P.M | ||
| Board Meeting | 13 Aug 2025 | 7 Aug 2025 |
| Lactose India Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 13/08/2025 inter alia to consider and approve 1. To consider and approve Un-Audited Financial Results of the Company along with the Limited Review Report issued by statutory auditor of the company for the First quarter ended 30th June 2025; 2. To consider and review Internal Audit Report; 3. To consider any other business with the permission of chair. In compliance with Regulation 30 and 33 of Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, this is to inform to the Exchange that the Board of Directors of the Company at their meeting held on Wednesday, 13th August 2025 has, inter alia, considered and approved the followings items of agenda: 1. Un-audited Financial Results along with the Limited Review Report issued by the Statutory Auditor of the Company for the first quarter ended 30th June, 2025. 2. Review and Approval of Internal Audit Report; The Meeting of the Board of Directors of the Company commenced at 03.00 P.M. and concluded at 04.30 P.M. (As Per BSE Announcement Dated on: 13.08.2025) | ||
| Board Meeting | 30 May 2025 | 21 May 2025 |
| Lactose India Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 30/05/2025 inter alia to consider and approve 1. Audited Financial Results of the Company for the fourth quarter and Financial year ended 31st March 2025. 2. To consider any other business with the permission of chair. In compliance with Regulation 30 and 33 of Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, this is to inform that the Board of Directors of the Company at their meeting held on Friday, 30th May, 2025 has, inter alia, considered and approved the followings items of agenda: 1. Audited Financial Results along with Auditors Report for the Fourth quarter and Financial year ended 31st March, 2025; Pursuant to Regulation 33(3)(d) of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, as amended. We do hereby confirm that the Statutory auditors of the Company, M/s. DMKH & Co. have expressed unmodified opinion(s) in its audit report pertaining to the audited financial results for the quarter and year ended 31st March, 2025. The Meeting of the Board of Directors of the Company was commenced at 12.30 P.M. and concluded at 01.40 P.M. We hereby submit the financial results for the fourth quarter and financial year ended 31st March 2025 along with the Independent Auditors Report. (As Per BSE Announcement Dated on 30.05.2025) | ||
| Board Meeting | 12 Feb 2025 | 6 Feb 2025 |
| LACTOSE (INDIA) LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 12/02/2025 inter alia to consider and approve 1. Draft Un-audited Financial Results of the Company along with Limited Review Report for the Third quarter ended 31st December 2024. 2. Any other business with the permission of chair In compliance with Regulation 30 of Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, this is to inform you that the Board of Directors at their meeting held today viz., Wednesday, 12th February 2025 has inter-alia approved the following items; 1. Unaudited Financial Results for the third quarter ended 31st December 2024. 2. Any other business as decided with the permission of the chairman. The Meeting of the Board of Directors of the Company was commenced at 03:30 P.M. and concluded at 04:30 P.M. (As Per BSE Announcement Dated on 12/02/2025) | ||
| Board Meeting | 5 Dec 2024 | 2 Dec 2024 |
| Inter alia, to consider and approve : 1. Allotment of 15,00,000 Convertible Warrants on preferential basis. 2. Any other business with the permission of chair. Lactose (India) Limited at its Board Meeting held on Thursday, 05th December, 2024 has approved allotment of 15,00,000 Convertible Warrants of Rs. 10/- each at an issue price of Rs.174/- (inclusive of premium Rs.164/-) on preferential basis. Further, the Company has made allotment against the in-principle approval received from BSE Limited dated 21st November, 2024 for issue of 15,00,000 warrants convertible in to equity shares. The Meeting of the Board of Directors of the Company was commenced at 11.00 a.m. and concluded at 11.30 a.m. Pursuant to Regulation 30 of SEBI (LODR) Regulation, 2015 and further the in-principle approval received from BSE Limited dated 21st November, 2024 for issue of 15,00,000 warrants convertible into equity shares, we hereby inform that the meeting of Board of Directors of the Company held on Thursday, 05th December, 2024 has approved the allotment on preferential basis. Kindly take the same on record and oblige. (As Per BSE Announcement Dated on 05.12.2024) | ||
| Board Meeting | 15 Nov 2024 | 15 Nov 2024 |
| Pursuant to Regulation 30 of SEBI (LODR) Regulations, 2015, this is to inform that upon recommendation of the Board, the shareholders of the Company at their meeting held on Friday, 15th November, 2024 has inter alia, considered and approved the agenda as mentioned in the Notice of EOGM. Kindly take the same on record and oblige. | ||
IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000
IIFL Capital Services Support WhatsApp Number
+91 9892691696
Download The App Now
Follow us on
2025, IIFL Capital Services Ltd. All Rights Reserved
IIFL Capital Services Limited - Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248, DP SEBI Reg. No. IN-DP-185-2016, BSE Enlistment Number (RA): 5016
ARN NO : 47791 (AMFI Registered Mutual Fund Distributor)
This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.